| Pyk2 (399-405) pY402 |
Protein tyrosine kinase 2 beta (S399-I405, human) pY402 peptide |
|
pe-04aqq99 |
Details |
| RPS6 (232-242) pS235+pS236+pS240 |
40S Ribosomal S6 (R232-S242, human) pS235+pS236+pS240 peptide |
|
pe-04aqr95 |
Details |
| MBP (228-235) pT232 |
Myelin basic protein (V228-P235, human) pT232 peptide |
|
pe-04aqs99 |
Details |
| MST1 (179-187) pT183 |
Mammalian STE20-like protein-serine kinase 1 (KRS2) / Serine-threonine-protein kinase 4 (A179-T187, human) pT183 peptide |
|
pe-04aqw95 |
Details |
| EEF2 (53-60) pT57 |
Eukaryotic elongation factor 2 (E53-R60, human) pT57 peptide |
|
pe-04aqy90 |
Details |
| ANXA1 (203-210) pY207 |
Annexin A1 (A203-G210, human) pY207 peptide |
|
pe-04arb95 |
Details |
| CREB (130-136) pS133 |
cAMP-response element-binding protein 1 (R130-K136, human) pS133 peptide |
|
pe-04are90 |
Details |
| KIT (818-827) pS821+pY823 |
Mast/stem cell growth factor receptor protein-tyrosine Kit (K818-G827, human) pS821+pY823 peptide |
|
pe-04arm95 |
Details |
| PDGFRA (846-853) pS847+pY849 |
Platelet-derived growth factor receptor kinase alpha (D846-G853, human) pS847+pY849 peptide |
|
pe-04arn60 |
Details |
| Lck (257-268) pY263+pY264 |
Lymphocyte-specific protein-tyrosine kinase / Proto-oncogene tyrosine-protein kinase Lck (G257-T268, human) pY263+pY264 peptide |
|
pe-04arp55 |
Details |
| PKCz (258-267) pS262+pY263 |
Protein-serine kinase C zeta (I258-L267, human) pS262+pY263 peptide |
|
pe-04arq99 |
Details |
| A-Raf (450-461) pT452+pT455+pS458 |
A-Raf proto-oncogene serine/threonine-protein kinase (L450-Q461, human) pT452+pT455+pS458 peptide |
|
pe-04ars99 |
Details |
| ASK1 (832-845) pT836+pT838+pT842 |
Apoptosis signal regulating protein-serine kinase 1 (N832-Y845, human) pT836+pT838+pT842 peptide |
|
pe-04art60 |
Details |
| AurB (219-230) pS222+pS227 |
Aurora Kinase B (serine/threonine protein kinase 12) (F219-R230, human) pS222+pS227 peptide |
|
pe-04arv95 |
Details |
| AurC (185-197) pS188+pT191 |
Aurora Kinase C (serine/threonine-protein kinase 13) (F185-R197, human) pS188+pT191 peptide |
|
pe-04arw90 |
Details |
| BARK1 (347-359) pS350+pT353+pY356 |
Beta-adrenergic receptor kinase 1 (P347-P359, human) pS350+pT353+pY356 peptide |
|
pe-04ary40 |
Details |
| CaMK1a (179-187) pT181+pY184 |
Calcium/calmodulin-dependent protein-serine kinase 1 alpha (C179-P187, human) pT181+pY184 peptide |
|
pe-04arz01 |
Details |
| CAMK4 (197-210) pT200+pT204+pY207 |
Calcium/calmodulin-dependent protein-serine kinase 4 (L197-P210, human) pT200+pT204+pY207 peptide |
|
pe-04asa60 |
Details |
| CAMK4 (197-203) pT200 |
Calcium/calmodulin-dependent protein-serine kinase 4 (L197-G203, human) pT200 peptide |
|
pe-04asb01 |
Details |
| CAMK4 (202-) pT204+pY207 |
Calcium/calmodulin-dependent protein-serine kinase 4 (C202-P210, human) pT204+pY207 peptide |
|
pe-04asc01 |
Details |
| CDK1 (10-23) pT14+pY15+pY19 |
Cyclin-dependent protein-serine kinase 1 / Cell division control protein 2 homologue (I10-H23, human) pT14+pY15+pY19 peptide; dimer |
|
pe-04asd90 |
Details |
| CDK1 (157-164) pY160+pT161 |
Cyclin-dependent protein-serine kinase 1 / Cell division control protein 2 homologue (I157-V164, human) pY160+pT161 peptide |
|
pe-04asf01 |
Details |
| CDK1 (164-172) pT166+pY169 |
Cyclin-dependent protein-serine kinase 1 / Cell division control protein 2 homologue (V164-P172, human) pT166+pY169 peptide |
|
pe-04asg01 |
Details |
| CDK1 (12-18) pT14+pY15 |
Cyclin-dependent protein-serine kinase 1 / Cell division control protein 2 homologue (E12-V18, human) pT14+pY15 peptide |
|
pe-04ash00 |
Details |
| CDK10 (193-207) pT196+pT201+pY204 |
Cyclin-dependent protein-serine kinase 10 [PISSLRE] (K193-P207, human) pT196+pT201+pY204 peptide |
|
pe-04asi90 |
Details |
| CDK10 (198-206) pT201+pY204 |
Cyclin-dependent protein-serine kinase 10 [PISSLRE] (K198-A206, human) pT201+pY204 peptide |
|
pe-04asj01 |
Details |
| CDK2 (155-163) pT158+pY159+pT160 |
Cyclin-dependent protein-serine kinase 2 (P155-V163, human) pT158+pY159+pT160 peptide; dimer |
|
pe-04ask95 |
Details |
| CDK2 (162-170) pT165+pY168 |
Cyclin-dependent protein-serine kinase 2 (E162-A170, human) pT165+pY168 peptide |
|
pe-04asl01 |
Details |
| CDK2 (162-171) pT165+pY168 |
Cyclin-dependent protein-serine kinase 2 (E162-P171, human) pT165+pY168 peptide |
|
pe-04asm85 |
Details |
| CDK3 (155-163) pT158+pY159+pT160 |
Cyclin-dependent protein-serine kinase 3 (P155-V163, human) pT158+pY159+pT160 peptide |
|
pe-04asn95 |
Details |
| CDK6 (174-182) pT177+pS178+pT182 |
Cyclin-dependent protein-serine kinase 6 (M174-T182, human) pT177+pS178+pT182 peptide |
|
pe-04aso01 |
Details |
| CDK9 (188-195) pT191+pY194 |
Cyclin-dependent protein-serine kinase 9 (R188-R195, human) pT191+pY194 peptide |
|
pe-04asp99 |
Details |
| CDK9 (188-195) pT191+pY194 |
Cyclin-dependent protein-serine kinase 9 (R188-R195, human) pT191+pY194 peptide |
|
pe-04asq01 |
Details |
| CDK9 (172-189) pS175+pS180+pY185+pT186 |
Cyclin-dependent protein-serine kinase 9 (R172-V189, human) pS175+pS180+pY185+pT186 peptide |
|
pe-04asr99 |
Details |
| CDKL5 (165-180) pY168+pT169+pY171+pT174+pY177 |
Cyclin-dependent kinase-like 5 / Serine-threonine-protein kinase 9 (N165-P180, human) pY168+pT169+pY171+pT174+pY177 peptide |
|
pe-04ass70 |
Details |
| CDKL5 (165-173) pY168+pT169+pY171 |
Cyclin-dependent kinase-like 5 / Serine-threonine-protein kinase 9 (N165-A173, human) pY168+pT169+pY171 peptide |
|
pe-04ast01 |
Details |
| CDKL5 (172-180) pT174+pY177 |
Cyclin-dependent kinase-like 5 / Serine-threonine-protein kinase 9 (V172-P180, human) pT174+pY177 peptide |
|
pe-04asu01 |
Details |
| CLK1 (334-348) pS337+pT338+pS341+pT342+pY345 |
Dual specificity protein kinase CLK1 (E334-P348, human) pS337+pT338+pS341+pT342+pY345 peptide |
|
pe-04asv90 |
Details |
| CLK1 (339-347) pS341+pT342+pY345 |
Dual specificity protein kinase CLK1 (L339-A347, human) pS341+pT342+pY345 peptide |
|
pe-04asw01 |
Details |
| DAPK3 (176-184) pT180 |
Death-associated protein kinase 3 (N176-V184, human) pT180 peptide |
|
pe-04asx95 |
Details |
| DYRK1A (316-330) pY319+pY321+pS324+pY327 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Q316-P330, human) pY319+pY321+pS324+pY327 peptide |
|
pe-04ata50 |
Details |
| DYRK1A (316-323) pY319+pY321 |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Q316-Q323, human) pY319+pY321 peptide |
|
pe-04atb01 |
Details |
| DYRK2 (379-385) pY382 |
Dual specificity tyrosine-phosphorylation-regulated kinase 2 (V379-S385, human) pY382 peptide |
|
pe-04atc00 |
Details |
| DYRK4 (259-273) pY262+pT263+pY264+pS267+pY270 |
Dual specificity tyrosine-phosphorylation-regulated kinase 4 (Q259-P273, human) pY262+pT263+pY264+pS267+pY270 peptide |
|
pe-04atd55 |
Details |
| EEF1A1 (26-32) pY29 |
Eukaryotic elongation factor 1-alpha 1 (H26-G32, human) pY29 peptide |
|
pe-04ate00 |
Details |
| EGFR (866-873) pY869 |
Epidermal growth factor receptor-tyrosine kinase (E866-G873, human) pY869 peptide |
|
pe-04atg01 |
Details |
| EphA3 (775-785) pY779+pT780+pT781 |
Ephrin type-A receptor 3 protein-tyrosine kinase (P775-K785, human) pY779+pT780+pT781 peptide |
|
pe-04ath99 |
Details |
| ErbB4 (872-879) pY875 |
ErbB4 receptor-tyrosine kinase (E872-G879, human) pY875 peptide |
|
pe-04ati01 |
Details |
| ERK1 (204-209) pT207 |
Extracellular regulated protein-serine kinase 1 (p44 MAP kinase) (Y204-W209, human) pT207 peptide |
|
pe-04atj95 |
Details |
| ERK1 (204-209) pY204 |
Extracellular regulated protein-serine kinase 1 (p44 MAP kinase) (Y204-W209, human) pY204 peptide |
|
pe-04atk95 |
Details |
| ERK1 (204-209) pY204+pT207 |
Extracellular regulated protein-serine kinase 1 (p44 MAP kinase) (Y204-W209, human) pY204+pT207 peptide |
|
pe-04atl90 |
Details |
| ERK1 (195-206) pT198+pT202+pY204 |
Extracellular regulated protein-serine kinase 1 (p44 MAP kinase) (H195-A206, human) pT198+pT202+pY204 peptide |
|
pe-04atm90 |
Details |
| ERK1 (199-206) pT202+pY204 |
Extracellular regulated protein-serine kinase 1 (p44 MAP kinase) (G199-A206, human) pT202+pY204 peptide |
|
pe-04atn01 |
Details |
| ERK1 (204-213) pT204+pT207+pY210 |
Extracellular regulated protein-serine kinase 1 (p44 MAP kinase) (Y204-P213, human) pT204+pT207+pY210 peptide |
|
pe-04ato95 |
Details |
| ERK1 (205-213) pT207+pY210 |
Extracellular regulated protein-serine kinase 1 (p44 MAP kinase) (V205-P213, human) pT207+pY210 peptide |
|
pe-04atp01 |
Details |
| ERK3 (191-200) pT194+pY197+pS199 |
Extracellular regulated protein-serine kinase 3 (G191-P200, human) pT194+pY197+pS199 peptide; dimer |
|
pe-04atq80 |
Details |
| ERK5 (217-223) pT219+pY221 |
Extracellular regulated protein-serine kinase 5 (Big MAP kinase 1 (BMK1)) (F217-A223, human) pT219+pY221 peptide |
|
pe-04ats75 |
Details |
| ERK7 (173-179) pT175+pY177 |
Mitogen-activated protein kinase 15 (A173-A179, human) pT175+pY177 peptide |
|
pe-04atv99 |
Details |
| ERK7 (172-179) pT175+pY177 |
Mitogen-activated protein kinase 15 (Q172-A179, human) pT175+pY177 peptide |
|
pe-04atw80 |
Details |
| FAK (568-573) pY570 |
Focal adhesion protein-tyrosine kinase (S568-D573, human) pY570 peptide |
|
pe-04aty99 |
Details |
| FAK (576-583) pY576+pY577+pS580 |
Focal adhesion protein-tyrosine kinase (Y576-K583, human) pY576+pY577+pS580 peptide |
|
pe-04aub01 |
Details |
| Fes (711-716) pY713 |
Fes/Fps protein-tyrosine kinase (G711-S716, human) pY713 peptide |
|
pe-04auc99 |
Details |
| FGFR1 (651-657) pY653+pY654 |
Fibroblast growth factor receptor-tyrosine kinase 1 / Basic fibroblast growth factor receptor 1 (I651-T657, human) pY653+pY654 peptide |
|
pe-04aud95 |
Details |
| FGFR1 (650-657) pY653+pY654 |
Fibroblast growth factor receptor-tyrosine kinase 1 / Basic fibroblast growth factor receptor 1 (H650-T657, human) pY653+pY654 peptide; dimer |
|
pe-04aue90 |
Details |
| FGFR3 (644-650) pY647 |
Fibroblast growth factor receptor 3 (N644-K650, human) pY647 peptide |
|
pe-04aug99 |
Details |
| FGFR3 (644-651) pY647+pY648 |
Fibroblast growth factor receptor 3 (N644-T651, human) pY647+pY648 peptide |
|
pe-04auh01 |
Details |
| KDR (1051-1063) pY1054+pY1059 |
Vascular endothelial growth factor receptor 2 / Vascular endothelial growth factor receptor-tyrosine kinase 2 (Flk1) (R1051-G1063, human) pY1054+pY1059 peptide |
|
pe-04aui75 |
Details |
| GCK (161-173) pS164+pS170 |
Germinal centre protein-serine kinase / Mitogen-activated protein kinase kinase kinase kinase 2 (L161-G173, human) pS164+pS170 peptide; dimer |
|
pe-04aun90 |
Details |
| GSK3a (275-288) pS278+pY279+pS282+pY284+pY285 |
Glycogen synthase-serine kinase 3 alpha (P275-P288, human) pS278+pY279+pS282+pY284+pY285 peptide |
|
pe-04auq95 |
Details |
| HPK1 (162-174) pT165+pS171 |
Mitogen-activated protein kinase kinase kinase kinase 1 (I162-G174, human) pT165+pS171 peptide |
|
pe-04auv99 |
Details |
| ICK (152-168) pY156+pT157+pY159+pS161+pT162+pY165 |
Intestinal cell (MAK-like) kinase (S152-P168, human) pY156+pT157+pY159+pS161+pT162+pY165 peptide |
|
pe-04auz75 |
Details |
| ILK (340-354) pS343+pY351 |
Integrin-linked protein-serine kinase-1 (V340-A354, human) pS343+pY351 peptide |
|
pe-04avd70 |
Details |
| JAK2 (1004-1019) pY1007+pY1008+pS1016 |
Janus protein-tyrosine kinase 2 (D1004-F1019, human) pY1007+pY1008+pS1016 peptide |
|
pe-04avn65 |
Details |
| JNK1 (185-194) pY185+pT188+pY191 |
Jun N-terminus protein-serine kinase (stress-activated protein kinase (SAPK)) 1 (Y185-P194, human) pY185+pT188+pY191 peptide |
|
pe-04avr80 |
Details |
| KHS1 (165-177) pT168 +pS174 |
Kinase homologous to SPS1/STE20 (MAP kinase kinase kinase protein-serine kinase 5 (MEKKK5) (I165-G177, human) pT168 +pS174 peptide; dimer |
|
pe-04avs95 |
Details |
| LOK (182-194) pT185+pS191 |
Lymphocyte-oriented protein-serine kinase / Serine-threonine-protein kinase 10 (N182-G194, human) pT185+pS191 peptide |
|
pe-04avy90 |
Details |
| MEK1 (219-225) pS222 |
MAPK/ERK protein-serine kinase 1 (MKK1) / Dual specificity mitogen-activated protein kinase kinase 1 (M219-G225, human) pS222 peptide |
|
pe-04awb00 |
Details |
| ERK2 (198-205) pT202 |
Extracellular regulated protein-serine kinase 2 (p42 MAP kinase) (G198-V205, human) pT202 peptide |
|
pe-04awc00 |
Details |
| JNK3 (220-226) pY223 |
Mitogen-activated protein kinase 10 (M220-T226, human) pY223 peptide |
|
pe-04awd00 |
Details |
| p38a (179-185) pT182 |
Mitogen-activated protein kinase 11 (M179-T185, human) pT182 peptide |
|
pe-04awe00 |
Details |
| MARK1 (212-226) pT215+pS219 |
MAP/microtubule affinity-regulating protein-serine kinase 1 (K212-P226, human) pT215+pS219 peptide |
|
pe-04awh80 |
Details |
| MEK3 (214-233) pS218+pT222+pY230 |
MAPK/ERK protein-serine kinase 3 beta isoform (MKK3 beta) / Dual specificity mitogen-activated protein kinase kinase 3 (Y214-P233, human) pS218+pT222+pY230 peptide |
|
pe-04awi70 |
Details |
| MELK (159-170) pY163+pT167 |
Maternal embryonic leucine zipper kinase (G159-G170, human) pY163+pT167 peptide |
|
pe-04awj90 |
Details |
| MERTK (746-657) pY749+pY753+pY754 |
Tyrosine-protein kinase Mer / Proto-oncogene tyrosine-protein kinase Mer (K746-G657, human) pY749+pY753+pY754 peptide |
|
pe-04awk80 |
Details |
| Met (1227-1244) pY1230+pY1234+pY1235+pS1236 |
Hepatocyte growth factor (HGF) receptor-tyrosine kinase (R1227-K1244, human) pY1230+pY1234+pY1235+pS1236 peptide |
|
pe-04awl80 |
Details |
| MOK (156-170) pT159+pY161+pT164+pY167 |
MAPK-MAK-MRK overlapping kinase / MOK protein kinase (Q156-P170, human) pT159+pY161+pT164+pY167 peptide |
|
pe-04awm75 |
Details |
| MSK2 (192-199) pS196 |
Ribosomal protein S6 kinase alpha-4 (E192-G199, human) pS196 peptide |
|
pe-04awn90 |
Details |
| MST1 (172-190) pT175+pT177+pT183+pT187 |
Mammalian STE20-like protein-serine kinase 1 (KRS2) / Serine-threonine-protein kinase 4 (G172-W190, human) pT175+pT177+pT183+pT187 peptide |
|
pe-04awo70 |
Details |
| MST3 (179-197) pT182+pT184+pT190+pT194 |
Mammalian STE20-like protein-serine kinase 3 / Serine-threonine-protein kinase 24 (G179-W197, human) pT182+pT184+pT190+pT194 peptide |
|
pe-04awp75 |
Details |
| MuSK (748-759) pY751+pY755+pY756 |
Muscle, skeletal receptor tyrosine-protein kinase (R748-N759, human) pY751+pY755+pY756 peptide |
|
pe-04awq90 |
Details |
| NDR1 (277-291) pS281+pT282+pT285+pY288 |
Serine/threonine-protein kinase 38 (Q277-P291, human) pS281+pT282+pT285+pY288 peptide |
|
pe-04awr85 |
Details |
| NLK (302-309) pT303+pY306 |
Serine/threonine protein kinase NLK (V302-P309, human) pT303+pY306 peptide |
|
pe-04aws99 |
Details |
| PAK1 (245-431) pT427+pY429 |
p21-activated kinase 1 alpha / Protein-serine/threonine kinase PAK 1 (V245-M431, human) pT427+pY429 peptide |
|
pe-04awt99 |
Details |
| PCTAIRE1 (323-330) pT324+pY327 |
Cell division protein kinase 16 / Protein-serine kinase PCTAIRE-1 (V323-P330, human) pT324+pY327 peptide |
|
pe-04awu99 |
Details |
| PGK1 (193-199) pY196 |
Phosphoglycerate kinase 1 (E193-K199, human) pY196 peptide |
|
pe-04awv00 |
Details |
| CDK11 (581-587) pY582+pT583 |
Cell division cycle 2-like 2 protein kinase (A581-V587, human) pY582+pT583 peptide, dimer |
|
pe-04awx99 |
Details |
| PKACa (201-208) pT202+pY205 |
cAMP-dependent protein kinase catalytic subunit alpha (G201-P208, human) pT202+pY205 peptide |
|
pe-04awy99 |
Details |
| PKD1 (735-752) pS738+pS742+pT746+pY749 |
Protein-serine kinase C mu (Protein kinase D) (G735-P752, human) pS738+pS742+pT746+pY749 peptide |
|
pe-04awz70 |
Details |
| PKG1 (518-527) pT521+pY524 |
cGMP-dependent protein kinase 1, alpha isozyme (F518-P527, human) pT521+pY524 peptide |
|
pe-04axa95 |
Details |
| PKR (443-457) pT446+pT451+pY454+pS456 |
Double-stranded RNA-dependent protein-serine kinase / Interferon-induced, double-stranded RNA-activated protein kinase (G443-P457, human) pT446+pT451+pY454+pS456 peptide |
|
pe-04axb80 |
Details |
